Other Species / Isoforms
  FKBP15 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S14-p
EDDTDFLsPSGGARL
Upstream
0 8
Treatment
  • nocodazole
  • selumetinib
  • vemurafenib
FKBP15 (human) EDDTDFLsPSGGARL S14-p
FKBP15 iso2 (human) EDDTDFLSPSGGARL S14
FKBP15 (mouse) EDDTDFLsPSGGAKL S14-p
FKBP15 (rat) NDILFSFSCNRAKLA S10
S23-p
SGGARLAsLFGLDQA
0 2
FKBP15 (human) SGGARLAsLFGLDQA S23-p
FKBP15 iso2 (human) SGGARLASLFGLDQA S23
FKBP15 (mouse) SGGAKLASLFGLDQA S23
FKBP15 (rat) CNRAKLASLFGLDQA S18
Y41-p
HGNEFFQytAPKQPK
0 30
FKBP15 (human) HGNEFFQytAPKQPK Y41-p
FKBP15 iso2 (human) HGNEFFQYTAPKQPK Y41
FKBP15 (mouse) HGNEFFQYTAPKQPK Y41
FKBP15 (rat) HGNEFFQYTAPKQPK Y36
T42-p
GNEFFQytAPKQPKK
0 5
FKBP15 (human) GNEFFQytAPKQPKK T42-p
FKBP15 iso2 (human) GNEFFQYTAPKQPKK T42
FKBP15 (mouse) GNEFFQYTAPKQPKK T42
FKBP15 (rat) GNEFFQYTAPKQPKK T37
T61-p
AATGNQAtPKTAPAT
0 2
FKBP15 (human) AATGNQAtPKTAPAT T61-p
FKBP15 iso2 (human) AATGNQATPKTAPAT T61
FKBP15 (mouse) TAAGNQTAPKPAPAT A60
FKBP15 (rat) AATGNQSAPKPAPAT A56
T73
PATMSTPTILVATAV
0 1
FKBP15 (human) PATMSTPTILVATAV T73
FKBP15 iso2 (human) PATMSTPTILVATAV T73
FKBP15 (mouse) PATTGTSsVLFATAV S72-p
FKBP15 (rat) PATTGTSSVLFATAV S68
K92-ac
YTNGQYVkQGKFGAA
0 1
FKBP15 (human) YTNGQYVkQGKFGAA K92-ac
FKBP15 iso2 (human) YTNGQYVKQGKFGAA K92
FKBP15 (mouse) YINGQYAKQGKFGAA K91
FKBP15 (rat) CINGQYAKQGKFGAA K87
S295-p
RVKFARDsGSDGHsV
0 3
FKBP15 (human) RVKFARDsGSDGHsV S295-p
FKBP15 iso2 (human) RVKFARDSGSDGHSV S295
FKBP15 (mouse) RVKFARDsGsDGHsV S294-p
FKBP15 (rat) KVKFARDSGSDGHSV S241
S297
KFARDsGSDGHsVsS
0 2
FKBP15 (human) KFARDsGSDGHsVsS S297
FKBP15 iso2 (human) KFARDSGSDGHSVSS S297
FKBP15 (mouse) KFARDsGsDGHsVSS S296-p
FKBP15 (rat) KFARDSGSDGHSVSS S243
S301-p
DsGSDGHsVsSRDsA
0 3
FKBP15 (human) DsGSDGHsVsSRDsA S301-p
FKBP15 iso2 (human) DSGSDGHSVSSRDSA S301
FKBP15 (mouse) DsGsDGHsVSSRDsA S300-p
FKBP15 (rat) DSGSDGHSVSSRDSA S247
S303-p
GSDGHsVsSRDsAAP
0 2
FKBP15 (human) GSDGHsVsSRDsAAP S303-p
FKBP15 iso2 (human) GSDGHSVSSRDSAAP S303
FKBP15 (mouse) GsDGHsVSSRDsAAP S302
FKBP15 (rat) GSDGHSVSSRDSAAP S249
S307-p
HsVsSRDsAAPsPIP
0 11
FKBP15 (human) HsVsSRDsAAPsPIP S307-p
FKBP15 iso2 (human) HSVSSRDSAAPSPIP S307
FKBP15 (mouse) HsVSSRDsAAPsPIP S306-p
FKBP15 (rat) HSVSSRDSAAPsPIP S253
S311-p
SRDsAAPsPIPGADN
Upstream
0 25
Treatment
  • ischemia
  • rapamycin
FKBP15 (human) SRDsAAPsPIPGADN S311-p
FKBP15 iso2 (human) SRDSAAPSPIPGADN S311
FKBP15 (mouse) SRDsAAPsPIPASDs S310-p
FKBP15 (rat) SRDSAAPsPIPAADS S257-p
N318
sPIPGADNLsADPVV
0 1
FKBP15 (human) sPIPGADNLsADPVV N318
FKBP15 iso2 (human) SPIPGADNLSADPVV N318
FKBP15 (mouse) sPIPASDsLsADPVV S317-p
FKBP15 (rat) sPIPAADSLSADPVV S264
S320-p
IPGADNLsADPVVsP
0 2
FKBP15 (human) IPGADNLsADPVVsP S320-p
FKBP15 iso2 (human) IPGADNLSADPVVSP S320
FKBP15 (mouse) IPASDsLsADPVVtP S319-p
FKBP15 (rat) IPAADSLSADPVVTP S266
S326-p
LsADPVVsPPtsIPF
Upstream
0 9
Treatment
  • ischemia
  • rapamycin
FKBP15 (human) LsADPVVsPPtsIPF S326-p
FKBP15 iso2 (human) LSADPVVSPPTSIPF S326
FKBP15 (mouse) LsADPVVtPLPLPLK T325-p
FKBP15 (rat) LSADPVVTPPLPLPL T272
T329-p
DPVVsPPtsIPFKSG
0 1
FKBP15 (human) DPVVsPPtsIPFKSG T329-p
FKBP15 iso2 (human) DPVVSPPTSIPFKSG T329
FKBP15 (mouse) ADPVVtPLPLPLKPG L327
FKBP15 (rat) DPVVTPPLPLPLKPG L275
S330-p
PVVsPPtsIPFKSGE
0 1
FKBP15 (human) PVVsPPtsIPFKSGE S330-p
FKBP15 iso2 (human) PVVSPPTSIPFKSGE S330
FKBP15 (mouse) DPVVtPLPLPLKPGE P328
FKBP15 (rat) PVVTPPLPLPLKPGE P276
T342-p
SGEPALRtKsNsLsE
0 11
FKBP15 (human) SGEPALRtKsNsLsE T342-p
FKBP15 iso2 (human) SGEPALRTKSNSLSE T342
FKBP15 (mouse) PGEPGLRsKsNsLsE S340-p
FKBP15 (rat) PGEPALRSKSSSVSE S288
S344-p
EPALRtKsNsLsEQL
Upstream
0 12
Treatment
  • nocodazole
FKBP15 (human) EPALRtKsNsLsEQL S344-p
FKBP15 iso2 (human) EPALRTKSNSLSEQL S344
FKBP15 (mouse) EPGLRsKsNsLsEQL S342-p
FKBP15 (rat) EPALRSKSSSVSEPL S290
S346-p
ALRtKsNsLsEQLAI
Upstream
0 24
Treatment
  • ischemia
FKBP15 (human) ALRtKsNsLsEQLAI S346-p
FKBP15 iso2 (human) ALRTKSNSLSEQLAI S346
FKBP15 (mouse) GLRsKsNsLsEQLtV S344-p
FKBP15 (rat) ALRSKSSSVSEPLTV S292
S348-p
RtKsNsLsEQLAINT
0 3
FKBP15 (human) RtKsNsLsEQLAINT S348-p
FKBP15 iso2 (human) RTKSNSLSEQLAINT S348
FKBP15 (mouse) RsKsNsLsEQLtVNS S346-p
FKBP15 (rat) RSKSSSVSEPLTVST S294
A352
NsLsEQLAINTsPDA
0 1
FKBP15 (human) NsLsEQLAINTsPDA A352
FKBP15 iso2 (human) NSLSEQLAINTSPDA A352
FKBP15 (mouse) NsLsEQLtVNSNPDT T350-p
FKBP15 (rat) SSVSEPLTVSTSPDT T298
S356-p
EQLAINTsPDAVKAK
Upstream
0 13
Treatment
  • nocodazole
FKBP15 (human) EQLAINTsPDAVKAK S356-p
FKBP15 iso2 (human) EQLAINTSPDAVKAK S356
FKBP15 (mouse) EQLtVNSNPDTVkAK N354
FKBP15 (rat) EPLTVSTSPDTAKAK S302
K361
NTsPDAVKAKLISRM
0 1
FKBP15 (human) NTsPDAVKAKLISRM K361
FKBP15 iso2 (human) NTSPDAVKAKLISRM K361
FKBP15 (mouse) NSNPDTVkAKLISRM K359-ub
FKBP15 (rat) STSPDTAKAKLISRM K307
S385
ILPPQLDSNDSEIED
0 2
FKBP15 (human) ILPPQLDSNDSEIED S385
FKBP15 iso2 (human) ILPPQLDSNDSEIED S385
FKBP15 (mouse) ILPPQLDsNDsEtED S383-p
FKBP15 (rat) ILPPQLDSNDsETED S331
S388
PQLDSNDSEIEDVNT
0 4
FKBP15 (human) PQLDSNDSEIEDVNT S388
FKBP15 iso2 (human) PQLDSNDSEIEDVNT S388
FKBP15 (mouse) PQLDsNDsEtEDATV S386-p
FKBP15 (rat) PQLDSNDsETEDATL S334-p
I390
LDSNDSEIEDVNTLQ
0 1
FKBP15 (human) LDSNDSEIEDVNTLQ I390
FKBP15 iso2 (human) LDSNDSEIEDVNTLQ I390
FKBP15 (mouse) LDsNDsEtEDATVLR T388-p
FKBP15 (rat) LDSNDsETEDATLLR T336
R520-m1
RQHNTEIrMAVSKVA
0 4
FKBP15 (human) RQHNTEIrMAVSKVA R520-m1
FKBP15 iso2 (human) RQHNTEIrMAVSKVA R520-m1
FKBP15 (mouse) RQHNTEIRMAVNKVA R518
FKBP15 (rat) RQHNTEIRMAVNKVA R466
R520
RQHNTEIRMAVSKVA
0 3
FKBP15 (human) RQHNTEIRMAVSKVA R520
FKBP15 iso2 (human) RQHNTEIRMAVSKVA R520
FKBP15 (mouse) RQHNTEIrMAVNKVA R518-m2
FKBP15 (rat) RQHNTEIRMAVNKVA R466
S555-p
SMLIPSMsVTMETSM
0 1
FKBP15 (human) SMLIPSMsVTMETSM S555-p
FKBP15 iso2 (human) SMLIPSMSVTMETSM S555
FKBP15 (mouse) SMLLPSMSVTMETSM S553
FKBP15 (rat) SMLLPSMSVTMETSM S501
K594-ub
RIEEQNDkISELIER
0 1
FKBP15 (human) RIEEQNDkISELIER K594-ub
FKBP15 iso2 (human) RIEEQNDKISELIER K594
FKBP15 (mouse) RIEEQNDKISDLIER K592
FKBP15 (rat) RIEEQNDKISDLIER K540
S619-p
MMEKRNNsLQTATEN
Upstream
0 13
Treatment
  • ischemia
FKBP15 (human) MMEKRNNsLQTATEN S619-p
FKBP15 iso2 (human) MMEKRNNSLQTATEN S619
FKBP15 (mouse) MMEKRNNsLQTATEN S617-p
FKBP15 (rat) MMEKRNNSLQTATEN S565
T660-p
SHLQLKMtAHQKKET
0 1
FKBP15 (human) SHLQLKMtAHQKKET T660-p
FKBP15 iso2 (human) SHLQLKMTAHQKKET T650
FKBP15 (mouse) SHLQLKMTAHQKkET T658
FKBP15 (rat) SHLQLKMTAHQKKET T606
K665
KMtAHQKKETELQMQ
0 1
FKBP15 (human) KMtAHQKKETELQMQ K665
FKBP15 iso2 (human) KMTAHQKKETELQMQ K655
FKBP15 (mouse) KMTAHQKkETELQLQ K663-ac
FKBP15 (rat) KMTAHQKKETELQLQ K611
K678
MQLTESLKETDLLRG
0 1
FKBP15 (human) MQLTESLKETDLLRG K678
FKBP15 iso2 (human) MQLTESLKETDLLRG K668
FKBP15 (mouse) LQLTDNLkETDLLRG K676-ac
FKBP15 (rat) LQLTENLKETDLLRG K624
S724
QLELKVTSLEEELTD
0 1
FKBP15 (human) QLELKVTSLEEELTD S724
FKBP15 iso2 (human) QLELKVTSLEEELTD S714
FKBP15 (mouse) QLELKVTsLEEELTD S722-p
FKBP15 (rat) QLELKVTSLEEELTD S670
E737
TDLRVEKESLEKNLS
0 1
FKBP15 (human) TDLRVEKESLEKNLS E737
FKBP15 iso2 (human) TDLRVEKESLEKNLS E727
FKBP15 (mouse) TDLRAEKtSLEKNLS T735-p
FKBP15 (rat) TDLRAEKESLEKNLS E683
S767-p
EIDEIRKsYQEELDk
0 1
FKBP15 (human) EIDEIRKsYQEELDk S767-p
FKBP15 iso2 (human) EIDEIRKSYQEELDK S757
FKBP15 (mouse) EMDEIRKSHQEELDR S765
FKBP15 (rat) EMDEIRKSHQEELDR S713
K774-ub
sYQEELDkLRQLLKK
0 2
FKBP15 (human) sYQEELDkLRQLLKK K774-ub
FKBP15 iso2 (human) SYQEELDKLRQLLKK K764
FKBP15 (mouse) SHQEELDRLRQLLKK R772
FKBP15 (rat) SHQEELDRLRQLLKK R720
S795-p
QAAAEQLsLVQAELQ
0 1
FKBP15 (human) QAAAEQLsLVQAELQ S795-p
FKBP15 iso2 (human) QAAAEQLSLVQAELQ S785
FKBP15 (mouse) QAAAEQLTLAQAELQ T793
FKBP15 (rat) QAAAEQLSLAQAELK S741
K808-ub
LQTQWEAkCEHLLAS
0 1
FKBP15 (human) LQTQWEAkCEHLLAS K808-ub
FKBP15 iso2 (human) LQTQWEAKCEHLLAS K798
FKBP15 (mouse) LQSQWEAKCEQLLAS K806
FKBP15 (rat) LKSQWEAKCEHLLAT K754
K837-ub
QRDAYQQkLVQLQEK
0 1
FKBP15 (human) QRDAYQQkLVQLQEK K837-ub
FKBP15 iso2 (human) QRDAYQQKLVQLQEK K827
FKBP15 (mouse) QRDAHQQKLALLQDE K835
FKBP15 (rat) QRDAYQQKLSHVQDE K783
S871
KELEKNKSQMsGVEA
0 1
FKBP15 (human) KELEKNKSQMsGVEA S871
FKBP15 iso2 (human) KELEKNKSQMSGVEA S861
FKBP15 (mouse) QRLEKTKsQAPAGRA S868-p
FKBP15 (rat) QRLEKSKSQAPAGRA S816
S874-p
EKNKSQMsGVEAAAS
0 1
FKBP15 (human) EKNKSQMsGVEAAAS S874-p
FKBP15 iso2 (human) EKNKSQMSGVEAAAS S864
FKBP15 (mouse) EKTKsQAPAGRAAAD P871
FKBP15 (rat) EKSKSQAPAGRAAAD P819
S939-p
QEQEKEEsssEEEEE
0 13
FKBP15 (human) QEQEKEEsssEEEEE S939-p
FKBP15 iso2 (human) QEQEKEESSSEEEEE S929
FKBP15 (mouse) gap -
FKBP15 (rat) QEEEQGECSSEEEKE C883
S940-p
EQEKEEsssEEEEEK
0 13
FKBP15 (human) EQEKEEsssEEEEEK S940-p
FKBP15 iso2 (human) EQEKEESSSEEEEEK S930
FKBP15 (mouse) gap -
FKBP15 (rat) EEEQGECSSEEEKEE S884
S941-p
QEKEEsssEEEEEKA
0 13
FKBP15 (human) QEKEEsssEEEEEKA S941-p
FKBP15 iso2 (human) QEKEESSSEEEEEKA S931
FKBP15 (mouse) gap -
FKBP15 (rat) EEQGECSSEEEKEEK S885
S956-p
EERPRRPsQEQsAsA
Upstream
0 98
Treatment
  • metastatic potential
FKBP15 (human) EERPRRPsQEQsAsA S956-p
FKBP15 iso2 (human) EERPRRPSQEQSASA S946
FKBP15 (mouse) EKKPLRPSLEQPGPA S948
FKBP15 (rat) EEKPLRPSLEQPGPA S897
S960-p
RRPsQEQsAsAssGQ
0 21
FKBP15 (human) RRPsQEQsAsAssGQ S960-p
FKBP15 iso2 (human) RRPSQEQSASASSGQ S950
FKBP15 (mouse) LRPSLEQPGPATPGM P952
FKBP15 (rat) LRPSLEQPGPATPRt P901
S962-p
PsQEQsAsAssGQPQ
0 11
FKBP15 (human) PsQEQsAsAssGQPQ S962-p
FKBP15 iso2 (human) PSQEQSASASSGQPQ S952
FKBP15 (mouse) PSLEQPGPATPGMPP P954
FKBP15 (rat) PSLEQPGPATPRtPL P903
S964-p
QEQsAsAssGQPQAP
0 1
FKBP15 (human) QEQsAsAssGQPQAP S964-p
FKBP15 iso2 (human) QEQSASASSGQPQAP S954
FKBP15 (mouse) LEQPGPATPGMPPAP T956
FKBP15 (rat) LEQPGPATPRtPLAL T905
S965-p
EQsAsAssGQPQAPL
0 2
FKBP15 (human) EQsAsAssGQPQAPL S965-p
FKBP15 iso2 (human) EQSASASSGQPQAPL S955
FKBP15 (mouse) EQPGPATPGMPPAPP P957
FKBP15 (rat) EQPGPATPRtPLALP P906
Q967
sAsAssGQPQAPLNR
0 1
FKBP15 (human) sAsAssGQPQAPLNR Q967
FKBP15 iso2 (human) SASASSGQPQAPLNR Q957
FKBP15 (mouse) PGPATPGMPPAPPSG M959
FKBP15 (rat) PGPATPRtPLALPSE T908-p
S979-p
LNRERPEsPMVPsEQ
Upstream
0 79
Treatment
  • ischemia
  • LRRK2-IN-1
FKBP15 (human) LNRERPEsPMVPsEQ S979-p
FKBP15 iso2 (human) LNRERPESPMVPSEQ S969
FKBP15 (mouse) PSGETQEAPEVLPEQ A971
FKBP15 (rat) PSEEPQEAPKVLSEQ A920
S984-p
PEsPMVPsEQVVEEA
0 21
FKBP15 (human) PEsPMVPsEQVVEEA S984-p
FKBP15 iso2 (human) PESPMVPSEQVVEEA S974
FKBP15 (mouse) QEAPEVLPEQVVGET P976
FKBP15 (rat) QEAPKVLSEQVEGET S925
S1012-p
GHRRKGDsEAEALsE
Upstream
0 6
Treatment
  • vemurafenib
FKBP15 (human) GHRRKGDsEAEALsE S1012-p
FKBP15 iso2 (human) GHRRKGDSEAEALSE S1002
FKBP15 (mouse) QTRKGEPAEAEVPSE A1006
FKBP15 (rat) QTRKGEPSEPEVSSE S955
S1018-p
DsEAEALsEIKDGsL
0 1
FKBP15 (human) DsEAEALsEIKDGsL S1018-p
FKBP15 iso2 (human) DSEAEALSEIKDGSL S1008
FKBP15 (mouse) PAEAEVPSEIKDSsL S1012
FKBP15 (rat) PSEPEVSSEIKDSsL S961
S1024-p
LsEIKDGsLPPELSC
Upstream
0 16
Treatment
  • ischemia
FKBP15 (human) LsEIKDGsLPPELSC S1024-p
FKBP15 iso2 (human) LSEIKDGSLPPELSC S1014
FKBP15 (mouse) PSEIKDSsLPPQPAG S1018-p
FKBP15 (rat) SSEIKDSsLPPEPAG S967-p
S1034-p
PELSCIPsHRVLGPP
0 1
FKBP15 (human) PELSCIPsHRVLGPP S1034-p
FKBP15 iso2 (human) PELSCIPSHRVLGPP S1024
FKBP15 (mouse) PQPAGIPAHRVLGPP A1028
FKBP15 (rat) PEPAGFPAHRVLGPP A977
S1056
LGPVSMDSECEEsLA
0 1
FKBP15 (human) LGPVSMDSECEEsLA S1056
FKBP15 iso2 (human) LGPVSMDSECEESLA S1046
FKBP15 (mouse) PGPVTMDsESEEMLA S1050-p
FKBP15 (rat) PGPVTIDSESEETVA S999
S1061-p
MDSECEEsLAAsPMA
0 1
FKBP15 (human) MDSECEEsLAAsPMA S1061-p
FKBP15 iso2 (human) MDSECEESLAASPMA S1051
FKBP15 (mouse) MDsESEEMLAADQRT M1055
FKBP15 (rat) IDSESEETVAAGQRT T1004
S1065-p
CEEsLAAsPMAAKPD
0 1
FKBP15 (human) CEEsLAAsPMAAKPD S1065-p
FKBP15 iso2 (human) CEESLAASPMAAKPD S1055
FKBP15 (mouse) SEEMLAADQRTVQPN D1059
FKBP15 (rat) SEETVAAGQRTLQPN G1008
S1092-p
PDGPLQEsstRLsLt
0 2
FKBP15 (human) PDGPLQEsstRLsLt S1092-p
FKBP15 iso2 (human) PDGPLQESSTRLSLT S1082
FKBP15 (mouse) TDGLLQGNSRRLsLt N1086
FKBP15 (rat) TDGLLQGNPRRLsLt N1035
S1093-p
DGPLQEsstRLsLts
0 1
FKBP15 (human) DGPLQEsstRLsLts S1093-p
FKBP15 iso2 (human) DGPLQESSTRLSLTS S1083
FKBP15 (mouse) DGLLQGNSRRLsLtP S1087
FKBP15 (rat) DGLLQGNPRRLsLtP P1036
T1094-p
GPLQEsstRLsLtsD
0 2
FKBP15 (human) GPLQEsstRLsLtsD T1094-p
FKBP15 iso2 (human) GPLQESSTRLSLTSD T1084
FKBP15 (mouse) GLLQGNSRRLsLtPD R1088
FKBP15 (rat) GLLQGNPRRLsLtPD R1037
S1097-p
QEsstRLsLtsDPEE
Upstream
0 33
Treatment
  • selumetinib
  • vemurafenib
FKBP15 (human) QEsstRLsLtsDPEE S1097-p
FKBP15 iso2 (human) QESSTRLSLTSDPEE S1087
FKBP15 (mouse) QGNSRRLsLtPDPEK S1091-p
FKBP15 (rat) QGNPRRLsLtPDPEK S1040-p
T1099-p
sstRLsLtsDPEEGD
0 16
FKBP15 (human) sstRLsLtsDPEEGD T1099-p
FKBP15 iso2 (human) SSTRLSLTSDPEEGD T1089
FKBP15 (mouse) NSRRLsLtPDPEKGE T1093-p
FKBP15 (rat) NPRRLsLtPDPEKKE T1042-p
S1100-p
stRLsLtsDPEEGDP
0 4
FKBP15 (human) stRLsLtsDPEEGDP S1100-p
FKBP15 iso2 (human) STRLSLTSDPEEGDP S1090
FKBP15 (mouse) SRRLsLtPDPEKGEP P1094
FKBP15 (rat) PRRLsLtPDPEKKEP P1043
S1114-p
PLALGPEsPGEPQPP
Upstream
0 27
Treatment
  • nocodazole
  • selumetinib
  • vemurafenib
FKBP15 (human) PLALGPEsPGEPQPP S1114-p
FKBP15 iso2 (human) PLALGPESPGEPQPP S1104
FKBP15 (mouse) PPALDPESQGGEAQP S1108
FKBP15 (rat) PPALDPESQEEPQPP S1057
T1141
PHKELSSTEAGSTVA
0 1
FKBP15 (human) PHKELSSTEAGSTVA T1141
FKBP15 iso2 (human) PHKELSSTEAGSTVA T1131
FKBP15 (mouse) PRETLLDtELASAAA T1136-p
FKBP15 (rat) GPCEVMDTERAAADT T1083
S1158-p
ALRPSHHsQRssLsG
0 3
FKBP15 (human) ALRPSHHsQRssLsG S1158-p
FKBP15 iso2 (human) ALRPSHHSQRSSLSG S1148
FKBP15 (mouse) SLRHNQDsQHCsLsG S1153-p
FKBP15 (rat) SPRHSQDSQHCSVsG S1100
S1161-p
PSHHsQRssLsGDEE
0 12
FKBP15 (human) PSHHsQRssLsGDEE S1161-p
FKBP15 iso2 (human) PSHHSQRSSLSGDEE S1151
FKBP15 (mouse) HNQDsQHCsLsGDEE C1156
FKBP15 (rat) HSQDSQHCSVsGDEE C1103
S1162-p
SHHsQRssLsGDEED
0 38
FKBP15 (human) SHHsQRssLsGDEED S1162-p
FKBP15 iso2 (human) SHHSQRSSLSGDEED S1152
FKBP15 (mouse) NQDsQHCsLsGDEED S1157-p
FKBP15 (rat) SQDSQHCSVsGDEED S1104
S1164-p
HsQRssLsGDEEDEL
Upstream
0 162
Treatment
  • anti-CD3
  • vemurafenib
FKBP15 (human) HsQRssLsGDEEDEL S1164-p
FKBP15 iso2 (human) HSQRSSLSGDEEDEL S1154
FKBP15 (mouse) DsQHCsLsGDEEDEL S1159-p
FKBP15 (rat) DSQHCSVsGDEEDEL S1106-p
S1195-p
EEDEDEVsMKGRPPP
0 11
FKBP15 (human) EEDEDEVsMKGRPPP S1195-p
FKBP15 iso2 (human) EEDEDEVSMKGRPPP S1185
FKBP15 (mouse) EEDEDEVsMKGRPPP S1190-p
FKBP15 (rat) EEDEDEVSMKGRPPP S1137
T1203-p
MKGRPPPtPLFGDDD
0 30
FKBP15 (human) MKGRPPPtPLFGDDD T1203-p
FKBP15 iso2 (human) MKGRPPPTPLFGDDD T1193
FKBP15 (mouse) MKGRPPPtPLFGDDD T1198-p
FKBP15 (rat) MKGRPPPTPLFGDDD T1145